In a continuous attempt to penetrate the huge untapped
) recently came up with the strategy to expand through
educational offerings. The company launched an interactive
website that provides professional education resources for
As a part of the company's password-protected portal
-Invisalign Doctor Site, this new educational offering will help
the company identify the doctors individually and provide
educational content and suggestions based on the geographic
location of the doctors, the relevant Invisalign product and
treatment option meeting their needs.
Align has tremendous growth opportunities in the malocclusion
market. It is estimated that malocclusion affects roughly a
billion individuals worldwide. Out of this,
approximately 6.8 million people annually elect treatment by
orthodontists worldwide. Further, 2.6 million people have
mild-to-moderate malocclusion and are eligible for Invisalign
Owing to compromised aesthetics, discomfort and other
drawbacks associated with traditional orthodontic treatments, a
relatively small number of people with malocclusion seek
treatment. As a result, the market is severely under
Realizing the fact that it can increase market share by
tapping the under-penetrated market, Align has undertaken several
strategies to improve the adoption of Invisalign that includes
product/technology development, extending clinical effectiveness,
extension of the Invisalign brand and driving international
The company is quite optimistic about the acceptance of
Invisalign i7 in UK across GP and Ortho channels. Moreover,
Invisalign Teen utilization trend in France is encouraging. China
and Japan, Align's latest direct country markets, are also
exhibiting strong growth.In China, the launch of Invisalign
during the second quarter of 2011 was followed by the
introduction of Invisalign 4 and Invisalign Teen in that
Align believes that the new features and functionality
delivered with Invisalign G3 and G4 are even more effective
outside North America, especially in Asia, due to the higher
complexity of cases among the Asian population. Over the long
term, we expect G4 and similar other innovations to act as major
catalysts to maintain Align's growth momentum in new as well as
The stock currently carries a Zacks Rank #3 (Hold). Other
medical device stocks worth a look are
Medical Action Industries Inc.
Given Imaging Ltd.
Acadia Health Company Inc.
). All these stocks carry a Zacks Rank #1 (Strong Buy).
ACADIA HEALTHCR (ACHC): Free Stock Analysis
ALIGN TECH INC (ALGN): Free Stock Analysis
GIVEN IMAGING (GIVN): Free Stock Analysis
MEDICAL ACTION (MDCI): Free Stock Analysis
To read this article on Zacks.com click here.